
																
																	Synergistic and additive antiproliferative effects on human leukemia cell lines induced by combining acetylenehexacarbonyldicobalt complexes with the tyrosine kinase inhibitor imatinib
																
																
																
															Keywords: لوسمی; Acetylenehexacarbonyldicobalt complexes; Synergism; Leukemia; Imatinib; Bioorganometallic chemistry;